2
by Guirguis-Blake, Janelle
Published 2018
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

3
by Guirguis-Blake, Janelle
Published 2018
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services

4
by Guirguis-Blake, Janelle, Beil, Tracy, Senger, Caitlyn A., Coppola, Erin L.
Published 2019
Agency for Healthcare Research and Quality
...]), largely driven by elective operations (Peto OR, 1.75 [95% CI, 1.61 to 1.90]). There was no statistically...

5
by Guirguis-Blake, Janelle, Beil, Tracy, Senger, Caitlyn A., Coppola, Erin L.
Published 2019
Agency for Healthcare Research and Quality
...]), largely driven by elective operations (Peto OR, 1.75 [95% CI, 1.61 to 1.90]). There was no statistically...

6
by Guirguis-Blake, Janelle, Webber, Elizabeth M., Coppola, Erin L.
Published 2021
Agency for Healthcare Research and Quality
...The smaller AMTEC trial (N=55) reported a statistically significantly lower composite risk...

7
by Guirguis-Blake, Janelle
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
... be unchanged or slightly reduced with a statistically significant benefit not persistent in dose sensitivity...

8
by Guirguis-Blake, Janelle
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
... be unchanged or slightly reduced with a statistically significant benefit not persistent in dose sensitivity...